tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

TPST Stock Latest News

Tempest Therapeutics announces FDA granted ODD to TPST-1495
The FlyTempest Therapeutics announces FDA granted ODD to TPST-1495
5d ago
TPST
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
14d ago
ADTX
CRMD
Tempest Therapeutics downgraded at Scotiabank as amezalpat finds no suitors
PremiumThe Fly
Tempest Therapeutics downgraded at Scotiabank as amezalpat finds no suitors
16d ago
CHRO
TPST
Tempest Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Tempest Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
16d ago
TPST
Tempest Therapeutics downgraded to Sector Perform from Outperform at Scotiabank
PremiumThe Fly
Tempest Therapeutics downgraded to Sector Perform from Outperform at Scotiabank
16d ago
TPST
Tempest Therapeutics Terminates Loan Agreement with Oxford
PremiumCompany AnnouncementsTempest Therapeutics Terminates Loan Agreement with Oxford
16d ago
8K
TPST
Tempest Therapeutics to explore strategic alternatives
Premium
The Fly
Tempest Therapeutics to explore strategic alternatives
16d ago
TPST
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
16d ago
BMY
ARTV
Tempest Therpeutics trading halted, news pending
PremiumThe Fly
Tempest Therpeutics trading halted, news pending
17d ago
TPST
Tempest Therapeutics treatment of FAP granted FDA orphan designation
PremiumThe Fly
Tempest Therapeutics treatment of FAP granted FDA orphan designation
25d ago
TPST
Tempest Therapeutics Advances Cancer Therapies Amid Financial Challenges
PremiumCompany Announcements
Tempest Therapeutics Advances Cancer Therapies Amid Financial Challenges
28d ago
TPST
Tempest Therapeutics price target lowered to $7 from $13 at Scotiabank
PremiumThe Fly
Tempest Therapeutics price target lowered to $7 from $13 at Scotiabank
28d ago
TPST
Tempest Therapeutics price target lowered to $16 from $47 at H.C. Wainwright
PremiumThe FlyTempest Therapeutics price target lowered to $16 from $47 at H.C. Wainwright
29d ago
TPST
Tempest Therapeutics received ‘Study May Proceed’ letter from FDA on TPST-1495
Premium
The Fly
Tempest Therapeutics received ‘Study May Proceed’ letter from FDA on TPST-1495
1M ago
TPST
Tempest Therapeutics granted FTD from FDA for amezalpat
Premium
The Fly
Tempest Therapeutics granted FTD from FDA for amezalpat
2M ago
TPST
Tempest Therapeutics receives ODD from FDA for TPST-1120
PremiumThe Fly
Tempest Therapeutics receives ODD from FDA for TPST-1120
4M ago
TPST
Tempest Therapeutics’ PPARalpha inhibitor receives FDA orphan designation
PremiumThe Fly
Tempest Therapeutics’ PPARalpha inhibitor receives FDA orphan designation
4M ago
TPST
Tempest Therapeutics Reports Q3 2024 Financial Results
PremiumCompany Announcements
Tempest Therapeutics Reports Q3 2024 Financial Results
5M ago
TPST
Tempest Therapeutics price target lowered to $5 from $8 at Piper Sandler
PremiumThe Fly
Tempest Therapeutics price target lowered to $5 from $8 at Piper Sandler
5M ago
TPST
Tempest Therapeutics reports Q3 EPS (41c), consensus (36c)
PremiumThe FlyTempest Therapeutics reports Q3 EPS (41c), consensus (36c)
5M ago
TPST
Tempest receives FDA study may proceed for Phase 3 trial of amezalpat
Premium
The Fly
Tempest receives FDA study may proceed for Phase 3 trial of amezalpat
5M ago
TPST
Tempest Therpeutics options imply 22.5% move in share price post-earnings
Premium
The Fly
Tempest Therpeutics options imply 22.5% move in share price post-earnings
6M ago
TPST

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >